The novel HDAC8 inhibitor WK2-16 attenuates lipopolysaccharide-activated matrix metalloproteinase-9 expression in human monocytic cells and improves hypercytokinemia in vivo
- Jing Shiun Jan
- , Yung Chen Chou
- , Yu Wen Cheng
- , Chih Kuang Chen
- , Wei Jan Huang
- , George Hsiao
- Department of Pharmaceutical Sciences
- Ph.D. Program in Drug Discovery and Development Industry
- School of Pharmacy
- Graduate Institute of Pharmacognosy
- International Master/Ph.D. Program in Medicine
- TMU Research Center of Drug Discovery
- TMU Research Center of Cell Therapy and Regeneration Medicine
- TMU Research Center of Neuroscience
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Master Program in Clinical Genomics and Proteomics
- Department of Ophthalmology
Research output: Contribution to journal › Article › peer-review
18
Link opens in a new tab
Citations
(Scopus)